Zotefoams 2025 presentation: profit surges 26% on margin expansion

Adjusted operating profit rose 26% to £22.8m and adjusted EPS jumped 46% to 38.00p, on revenue up 7% to £158.5m and a 220bp expansion in adjusted operating margin to 14.4%, delivering record profitability. The company completed the OKC acquisition (up to €36.0m, ~7x 2024 EBITDA €5.3m) which management expects to be earnings‑accretive, reduced leverage to 0.8x, generated £39.7m from operations, and proposed a 5% dividend increase. Management set medium‑term targets of revenue >£230m and operating profit >£40m by FY2029, while risks include a 17.6% revenue decline in Asia and expected normalization of footwear volumes.

Analysis

The market is rewarding execution but the real lever is operating gearing: incremental volume or mix improvement will flow almost entirely to the bottom line given current fixed-cost absorption, while any shortfall in end-market volumes will show up disproportionately in reported margins. That asymmetry creates a convex payoff — small positive demand surprises can materially lift EPS, but downside is amplified during startup/integration phases when one-off costs and underutilised new capacity bite.

Second-order winners include footwear OEMs and regional contract manufacturers that gain from reduced logistics lead times and localized foam supply, while legacy foam suppliers with higher-cost footprints or slower local expansion face margin pressure. Currency and feedstock exposures will be key hidden drivers: a stronger dollar or higher petrochemical-linked feedstock costs compress margins and can negate price realization efforts, creating a 3–9 month lag between input inflation and reported margin impact.

M&A and capital allocation are the other pivot. Management’s willingness to pay a premium for strategic targets accelerates market access but raises integration and return-risk if cross-selling or cost synergies under-deliver. Watch corporate cash conversion and R&D cadence — if capex and acquisition spend crowd out discretionary buybacks/dividends, investor sentiment will re-price the stock despite operational progress.

Key Decisions for Investors

• Long ZTF (LON:ZTF) 12–18 month equity position: enter on any >5% pullback, target +30–45% total return, initial stop-loss -18%. Rationale: asymmetric EPS upside from operational gearing; monitor months-to-quarterly updates for margin trajectory to add.
• Pair trade: long ZTF / short Rogers Corp (NYSE:ROG) over 9–15 months — go 1:1 notional. Expect ZTF to earn a multiple re-rating from growth/structural wins while ROG, more exposed to legacy industrial cyclicality, lags. Risk/reward ~2:1 if ZTF outperforms by 30% vs ROG down 10%; hedge if macro demand contracts.
• Buy ZTF protective put collar if concerned about near-term integration risk: buy ZTF stock and sell a nearer-term out-of-the-money call while buying a put 12 months out (cost ~paid by call). Limits upside but caps downside to ~-20% while preserving upside to +25–30% on event-driven recovery.
• Event catalyst short: initiate a small short on overlevered footwear suppliers or component peers that report high inventory or extended receivables in next 2–6 quarters (use names based on upcoming results). Rationale: normalization in footwear volumes will reveal excess working capital and margin pressure — target 15–25% downside with tight stop if inventory turn metrics improve unexpectedly.